Virbac
An independent pharmaceutical company exclusively dedicated to animal health.
FR000 | PA
Overview
Corporate Details
- ISIN(s):
- FR0000031577
- LEI:
- 969500QQ1X5XHG649644
- Country:
- France
- Address:
- 1ERE AVENUE, 06510 CARROS
- Sector:
- Manufacturing
Description
Virbac is an independent pharmaceutical company exclusively dedicated to animal health. Founded in 1968 by a veterinarian, the company provides veterinarians, farmers, and pet owners with a comprehensive range of products and services. Its portfolio of innovative solutions covers the majority of animal species and diseases, with a focus on both companion and farm animals. Key product areas include vaccines, dermatology, parasite control, dental care, nutrition, and diagnostics. Through its international R&D network, Virbac develops solutions to prevent, diagnose, and treat animal pathologies, contributing to animal welfare and supporting sustainable farming.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-16 17:45 |
VIRBAC annonce son chiffre d'affaires pour le troisième trimestre 2025
|
French | 585.4 KB | ||
| 2025-10-16 17:45 |
VIRBAC Announces Third Quarter 2025 Sales
|
English | 627.5 KB | ||
| 2025-09-12 17:45 |
VIRBAC: résultats semestriels 2025
|
French | 1.2 MB | ||
| 2025-09-12 17:45 |
Virbac: 2025 Half-year results
|
English | 1.1 MB | ||
| 2025-09-12 17:30 |
Virbac : Rapport financier semestriel 2025
|
French | 13.2 MB | ||
| 2025-09-12 17:30 |
Virbac : Half-yearly financial report 2025
|
English | 13.4 MB | ||
| 2025-09-12 17:30 |
Virbac : Communiqué de mise à disposition du rapport financier semestriel au 30…
|
French | 264.9 KB | ||
| 2025-09-12 17:30 |
Virbac : Public release of the Half-Year Financial Report at 30 June 2025.
|
English | 264.6 KB | ||
| 2025-08-18 09:30 |
VIRBAC: Informations sur les conditions de rémunération de Paul Martingell
|
French | 80.5 KB | ||
| 2025-08-18 09:30 |
Virbac:: Paul Martingell's compensation terms
|
English | 128.7 KB | ||
| 2025-06-19 08:30 |
VIRBAC: Paul Martingell nommé directeur général du groupe Virbac au 1er septemb…
|
French | 271.7 KB | ||
| 2025-06-19 08:30 |
VIRBAC: Paul Martingell is appointed chief executive officer of Virbac, effecti…
|
English | 279.3 KB | ||
| 2025-06-10 09:59 |
Virbac : Declaration of the number of share and voting rights 05/2025
|
English | 59.2 KB | ||
| 2025-06-10 09:59 |
Virbac : Déclaration d'actions et de droits de vote 05/2025
|
French | 36.6 KB | ||
| 2025-05-26 10:05 |
VIRBAC: Communiqué précisant les modalités de mise à disposition ou de consulta…
|
French | 26.3 KB |
Automate Your Workflow. Get a real-time feed of all Virbac filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Virbac
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Virbac via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-04-17 | N/A | Other | Sell | 370 | 135,790.00 EUR |
| 2023-07-19 | N/A | Other | Buy | 950 | 245,100.00 EUR |
Peer Companies
